What You Need to Know About Inherited Retinal Disease in the Age of Molecular Medicine
This webinar will take place on Thursday, May 19, 2022 at 7:30 pm EST.
Dr. Brian Ballios will provide a presentation entitled What you need to know about inherited retinal disease in the age of molecular medicine, followed by Q&A with the audience, moderated by Dr. Jim Whelan.


Dr. Ballios is a fellowship-trained clinician-scientist, with a focus on medical retinal disease and a subspecialty in inherited retinal disease. He is an Assistant Professor in the Department of Ophthalmology and Vision Sciences at the University of Toronto. He holds appointment as clinician-scientist at the University Health Network in the Donald K. Johnson Eye Institute, and is a staff physician at Sunnybrook Health Sciences Centre, and the Kensington Vision and Research Centre. He is a Scientist at the Krembil Research Institute where he has a laboratory investigating the mechanisms of acquired and inherited retinal disease, and the development of new stem cell-based therapies.
Dr. Ballios obtained his MD and PhD degrees at the University of Toronto in the combined MD/PhD program. With a background in material science and Engineering Chemistry (Queen’s University), his doctoral work focused on new approaches to the transplantation of stem cells and their progeny for the treatment of retinal degeneration. After completing his FRCSC in Ophthalmology at the University of Toronto, he undertook a subspecialty clinical fellowship in Inherited Retinal Disease at Massachusetts Eye and Ear and Harvard University.
Learning Objectives
At the end of this webinar, participants will be able to:
- Explain the importance of genetic testing and counseling for Inherited Retinal Dystrophies (IRD) patients and their families
- Effectively communicate the potential benefits of current and emerging gene therapies
- Identify genetic testing and counseling resources in their respective regions and confidently refer patients accordingly
CPD Credits
This webinar is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Ophthalmological Society. You may claim a maximum of 1 hour.
This webinar is co-developed by the COS and Novartis to achieve scientific integrity, objectivity, and balance.

DOVS CORNEA ROUNDS – Ions in KC and other fun-ky corneas
Date: Thursday March 17, 2022
Time: 5:00 PM – 6:00 PM
Topic: IOL calculations in KC and other fun-ky corneas
Speaker – Dr. Joshua Teichman
Zoom link – Register in advance for this webinar:

OBJECTIVES
1. Identify corneas that are more likely to cause issues with IOL calculations
2. Discuss inherent issues with biometry that must be considered when calculating IOLs in abnormal corneas
3. Discuss techniques and formulae that will improve the accuracy of IOL selection in abnormal corneas
World Cornea Congress – Chicago, IL

Date: September 28th–29th, 2022
IMPORTANT DATES
Jan 3 – Abstract Submissions Open for Scientific Papers and Electronic Posters
April 15 – Deadline for Abstract Submissions
May 3 – Early Registration Deadline
Jul 31 – Program Preview Available Online
Aug 12 – Advance Registration Deadline
Sept 28–29 – World Cornea Congress VIII
For more details visit the World Cornea Congress website
ESCRS (European Society of Cataract & Refractive Surgeons)
Date: September 16th-20th, 2022

We are pleased to inform you that the 40th Congress of the ESCRS will take place at the MiCo Milano Convention Centre, Milan, Italy from Friday 16 to Tuesday 20 September 2022.
The Congress will be a primarily face-to-face event, supported by a number of virtual elements. ESCRS is proud to have been among the first international healthcare societies to return to “live” meetings in 2021 and is excited to continue in this direction in 2022.
Registration information will be released here soon.
For more details visit the ESCRS website
DOVS RESIDENT TEACHING – Phakomatoses/Angiomatous tumors AND Disease of the Viteous, trauma and vitreoretinal surgery
Date: Friday March 11, 2022
Time: 8:45 AM – 10:45 AM ***11:00 AM – 12:00 PM BLOCK EXAM FOR UOFT RESIDENTS ONLY***
Topic: Phakomatoses/Angiomatous tumors AND Disease of the Viteous, trauma and vitreoretinal surgery
Speakers: Drs. Keyvan Koushan, Rajeev Muni
Zoom Link:

Passcode: 372580
DOVS GRAND ROUNDS – Case-based review of viral retinitis and white dot syndromes
Date: Friday March 11, 2022
Time: 7:30 AM – 8:30 AM
Topic: Case-based review of viral retinitis and white dot syndromes
Speaker: Dr. Keyvan Koushan
Zoom Link:

Passcode: 121363
OBJECTIVES
1.To review common risk factors, clinical features and treatment options for viral retinitis.
2.To review white dot syndromes and their masquerades.
DOVS CORNEA ROUNDS – Corneal Humps, Lumps and Bumps. How to navigate smoothly on a bumpy road… (Part 2)
Date: Thursday March 10, 2022
Time: 5:00 PM – 6:00 PM
Topic: Corneal Humps, Lumps and Bumps. How to navigate smoothly on a bumpy road… (Part 2)
Speakers: Drs. Yishay Weill and David Zadok
Zoom Link: Register in advance for this webinar:

After registering, you will receive a confirmation email containing information about joining the webinar.
OBJECTIVES
1. Diagnosis of common corneal surface pathologies
2. Indications for treatment and different therapeutic approaches
3. The value of treating corneal irregularities prior to cataract surgery
2022 CADTH Information Session
Virtual information session on CADTH’s priority initiatives and an introduction to the new 2022 – 2025 Strategic Plan.
Date: Tuesday, April 5, 2022
Time: 11:00 a.m. EST to 3:30 p.m. EST
Highlights:
- Remarks from David Agnew, Chair, CADTH Board of Directors
- Remarks from Dr. Stephen Lucas, Deputy Minister, Health Canada
- Presentations from CADTH’s leadership team
- Question and answer opportunities

Questions? Contact [email protected]
Save the Date: 2022 CADTH Information Session
Date: Tuesday, April 5, 2022
Time: 11:00 a.m. EST to 3:30 p.m. EST
CADTH is pleased to invite you to a one-day virtual information session on CADTH’s priority initiatives and an introduction to our new 2022–2025 Strategic Plan.
For more information click on the link below:
